NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States. Department of Health and Human Services. Remove constraint Subjects: United States. Department of Health and Human Services. Languages English Remove constraint Languages: English Publication Year 2017 to 2019 Remove constraint Publication Year: <span class="from" data-blrl-begin="2017">2017</span> to <span class="to" data-blrl-end="2019">2019</span>

Search Results

161. Chronic hepatitis C virus infection: developing direct-acting antiviral drugs for treatment

162. Recurrent herpes labialis: developing drugs for treatment and prevention

163. Evaluating drug effects on the ability to operate a motor vehicle

164. Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use : guidance for industry and Food and Drug Administration staff

165. Same surgical procedure exception under 21 CFR 1271.15(b): questions and answers regarding the scope of the exception

166. Unique device identification: direct marking of devices : guidance for Industry and Food and Drug administration staff

167. General principles for evaluating the abuse deterrence of generic solid oral opioid drug products

168. Pediatric information for x-ray imaging device premarket notifications: guidance for industry and Food and Drug Administration staff

169. Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry

170. FDA categorization of investigational device exemption (IDE) devices to assist the Centers for Medicare and Medicaid Services (CMS) with coverage decisions: guidance for sponsors, clinical investigators, industry, institutional review boards, and Food and Drug Administration staff